Filtered By:
Management: Health Insurance
Countries: Hungary Health

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 4 results found since Jan 2013.

Daylight saving time and the incidence of thrombolysis to treat acute ischemic stroke.
CONCLUSIONS: Our findings reflect that psychosocial factors, such as the approach of the last day of the month override the intrinsic effect of disturbances of the circadian rhythm on stroke incidence. PMID: 32241570 [PubMed - as supplied by publisher]
Source: Revue Neurologique - April 4, 2020 Category: Neurology Tags: Rev Neurol (Paris) Source Type: research

Old and new oral anticoagulants in the management of atrial fibrillation. Hungarian data.
CONCLUSIONS: We need more effort to improve the effective and high adherence oral anticoagulant therapy in our country. Orv Hetil. 2017; 158(39): 1545-1549. PMID: 28942666 [PubMed - in process]
Source: Orvosi Hetilap - September 26, 2017 Category: General Medicine Authors: Tomcsányi J, Salfer B, Nagy B Tags: Orv Hetil Source Type: research

Economic and public health benefits: the result of increased regular physical activity
Conclusion Only a 10% increase in physical activity would result in more than 28 billion HUF (ca. 73.7 million GBP) savings for the Hungarian economy.
Source: European Journal of Integrative Medicine - November 8, 2016 Category: Complementary Medicine Source Type: research

Or ális antikoagulánssal kezelt pitvarfibrilláló betegek terápiahűsége a mindennapokban.
Conclusions: The one-year persistence of NOACs was significantly higher in AF compared to VKA therapy (in therapy-naïve and in already treated patients, too). Among the NOACs, rivaroxaban has the best one-year persistence in all patient populations. Orv Hetil. 2020; 161(20): 839-845. PMID: 32364687 [PubMed - in process]
Source: Orvosi Hetilap - April 30, 2020 Category: General Medicine Authors: Simonyi G, Paksy A, Várnai R, Medvegy M Tags: Orv Hetil Source Type: research